Literature DB >> 27649986

[Cerebrospinal fluid diagnostics in multiple sclerosis].

K Ruprecht1, H Tumani2,3.   

Abstract

As a chronic inflammatory disease of the central nervous system (CNS), multiple sclerosis (MS) is associated with characteristic abnormalities in cerebrospinal fluid (CSF). Thus, in addition to magnetic resonance imaging, CSF examination is a central diagnostic procedure in patients with MS, which can corroborate a diagnosis of MS and may also help to discern differential diagnoses. The most important CSF finding in MS is the detection of persistent polyspecific intrathecal immunoglobulin synthesis. This review summarizes CSF findings of patients with MS and addresses issues of relevance for clinical practice, potential diagnostic pitfalls as well as new developments in CSF diagnostics of MS.

Entities:  

Keywords:  Cerebrospinal fluid; Diagnosis; Differential diagnosis; Immunoglobulins; Oligoclonal bands

Mesh:

Substances:

Year:  2016        PMID: 27649986     DOI: 10.1007/s00115-016-0220-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  32 in total

1.  Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Authors:  Martin Gunnarsson; Clas Malmeström; Markus Axelsson; Peter Sundström; Charlotte Dahle; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Niklas Norgren; Lars Rosengren; Anders Svenningsson; Jan Lycke
Journal:  Ann Neurol       Date:  2010-12-08       Impact factor: 10.422

2.  Blood-CSF barrier integrity in multiple sclerosis.

Authors:  R Liebsch; M E Kornhuber; D Dietl; H Gräfin von Einsiedel; B Conrad
Journal:  Acta Neurol Scand       Date:  1996-12       Impact factor: 3.209

3.  High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis.

Authors:  G Hassan-Smith; L Durant; A Tsentemeidou; L K Assi; J M Faint; S Kalra; M R Douglas; S J Curnow
Journal:  J Neuroimmunol       Date:  2014-08-08       Impact factor: 3.478

4.  Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Authors:  J Kuhle; G Disanto; R Dobson; R Adiutori; L Bianchi; J Topping; J P Bestwick; U-C Meier; M Marta; G Dalla Costa; T Runia; E Evdoshenko; N Lazareva; E Thouvenot; P Iaffaldano; V Direnzo; M Khademi; F Piehl; M Comabella; M Sombekke; J Killestein; H Hegen; S Rauch; S D'Alfonso; J C Alvarez-Cermeño; P Kleinová; D Horáková; R Roesler; F Lauda; S Llufriu; T Avsar; U Uygunoglu; A Altintas; S Saip; T Menge; C Rajda; R Bergamaschi; N Moll; M Khalil; R Marignier; I Dujmovic; H Larsson; C Malmestrom; E Scarpini; C Fenoglio; S Wergeland; A Laroni; V Annibali; S Romano; A D Martínez; A Carra; M Salvetti; A Uccelli; Ø Torkildsen; K M Myhr; D Galimberti; K Rejdak; J Lycke; J L Frederiksen; J Drulovic; C Confavreux; D Brassat; C Enzinger; S Fuchs; I Bosca; J Pelletier; C Picard; E Colombo; D Franciotta; T Derfuss; Rlp Lindberg; Ö Yaldizli; L Vécsei; B C Kieseier; H P Hartung; P Villoslada; A Siva; A Saiz; H Tumani; E Havrdová; L M Villar; M Leone; N Barizzone; F Deisenhammer; C Teunissen; X Montalban; M Tintoré; T Olsson; M Trojano; S Lehmann; G Castelnovo; S Lapin; R Hintzen; L Kappos; R Furlan; V Martinelli; G Comi; S V Ramagopalan; G Giovannoni
Journal:  Mult Scler       Date:  2015-02-13       Impact factor: 6.312

Review 5.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

6.  Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Authors:  M Tintoré; A Rovira; J Río; C Tur; R Pelayo; C Nos; N Téllez; H Perkal; M Comabella; J Sastre-Garriga; X Montalban
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

7.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications.

Authors:  Hela-Felicitas Petereit; Dirk Reske
Journal:  Cerebrospinal Fluid Res       Date:  2005-06-27

8.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

9.  Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.

Authors:  Isabel Brecht; Benedikt Weissbrich; Julia Braun; Klaus Viktor Toyka; Andreas Weishaupt; Mathias Buttmann
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

10.  Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.

Authors:  Makbule Senel; Hayrettin Tumani; Florian Lauda; Stefan Presslauer; Rehaneh Mojib-Yezdani; Markus Otto; Johannes Brettschneider
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more
  3 in total

Review 1.  [Strategies for cerebrospinal fluid analysis - Integrated results report].

Authors:  M Uhr; H Tumani; P Lange
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

2.  S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version).

Authors:  H Tumani; H F Petereit; A Gerritzen; C C Gross; A Huss; S Isenmann; S Jesse; M Khalil; P Lewczuk; J Lewerenz; F Leypoldt; N Melzer; S G Meuth; M Otto; K Ruprecht; E Sindern; A Spreer; M Stangel; H Strik; M Uhr; J Vogelgsang; K-P Wandinger; T Weber; M Wick; B Wildemann; J Wiltfang; D Woitalla; I Zerr; T Zimmermann
Journal:  Neurol Res Pract       Date:  2020-03-16

3.  Ion Mobility Mass Spectrometry Reveals Rare Sialylated Glycosphingolipid Structures in Human Cerebrospinal Fluid.

Authors:  Mirela Sarbu; Dragana Fabris; Željka Vukelić; David E Clemmer; Alina D Zamfir
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.